ADR · ASX

Adherium Ltd. (ASX:ADR)

AU$0.0045

 5.0E-4 (12.5%)
ASX:Live
18/09/2025 10:57:38 AM
Near Support Near 52 Week Low HALO Ords GROWTH AUS Big Candle +2
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

ADR Overview

ADR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Weak

GARP

Very Weak

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ADR

Telephone

N/A

Address

Description

Adherium Ltd. engages in the development, manufacture, and supply of digital health technologies. It operates through the following geographical segments: New Zealand and Australia, South-East Asian Countries, and Other Countries. The firm's Hailie system is transforming management of chronic respiratory conditions, especially asthma and chronic obstructive pulmonary disease. The company was founded by Garth Sutherland in 2001 and is headquartered in Melbourne, Australia.

ADR Price Chart

Key Stats

Market Cap

AU$7.45M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.01

Trade Value (12mth)

US$811.00

1 week

-20%

1 month

-20%

YTD

-66.67%

1 year

-66.67%

All time high

8.84

Key Fundamentals

EPS 3 yr Growth

-78.70%

EBITDA Margin

%

Operating Cashflow

-$10m

Free Cash Flow Return

-198.80%

ROIC

-252.50%

Interest Coverage

-74.80

Quick Ratio

0.00

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Next Company Report Date

28-Aug-26

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

NZD

Short Sell (% of issue)

0.00

ADR Announcements

Latest Announcements

Date Announcements

15 September 25

iCARE Study Hailie Smartinhaler Improves Patient Adherence

×

iCARE Study Hailie Smartinhaler Improves Patient Adherence

08 September 25

Application for quotation of securities - ADR

×

Application for quotation of securities - ADR

08 September 25

Cleansing Notice

×

Cleansing Notice

05 September 25

Notification regarding unquoted securities - ADR

×

Notification regarding unquoted securities - ADR

05 September 25

Change of Director's Interest Notice - L Panaccio

×

Change of Director's Interest Notice - L Panaccio

05 September 25

Change of Director's Interest Notice - G Baran

×

Change of Director's Interest Notice - G Baran

05 September 25

Late Lodgement of Appendices 3Y

×

Late Lodgement of Appendices 3Y

29 August 25

Preliminary Final Report

×

Preliminary Final Report

07 August 25

Change in substantial holding

×

Change in substantial holding

05 August 25

Notification regarding unquoted securities - ADR

×

Notification regarding unquoted securities - ADR

04 August 25

Firm commitments received for institutional placement

×

Firm commitments received for institutional placement

04 August 25

Proposed issue of securities - ADR

×

Proposed issue of securities - ADR

04 August 25

Application for quotation of securities - ADR

×

Application for quotation of securities - ADR

04 August 25

Cleansing Notice

×

Cleansing Notice

01 August 25

Change in substantial holding

×

Change in substantial holding

31 July 25

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

25 July 25

Notification of cessation of securities - ADR

×

Notification of cessation of securities - ADR

25 July 25

Appendix 3H

×

Appendix 3H

25 July 25

Change in substantial holding

×

Change in substantial holding

24 July 25

Change in substantial holding

×

Change in substantial holding

24 July 25

Change in substantial holding

×

Change in substantial holding

24 July 25

Change in substantial holding

×

Change in substantial holding

22 July 25

Adherium Appoints Dawn Bitz as CEO

×

Adherium Appoints Dawn Bitz as CEO

22 July 25

Application for quotation of securities - ADR

×

Application for quotation of securities - ADR

22 July 25

Notification regarding unquoted securities - ADR

×

Notification regarding unquoted securities - ADR

22 July 25

Change in substantial holding

×

Change in substantial holding

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ADR Shortsell

Frequently Asked Questions

The current share price of Adherium Ltd. (ADR:ASX) is AU$0.0045.
The 52-week high share price for Adherium Ltd. (ADR:ASX) is AU$0.01.
The 52-week low share price for Adherium Ltd. (ADR:ASX)? is AU$0.00.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) has a franking level of 0.0%.
Adherium Ltd. (ADR:ASX) is classified in the Healthcare.
The current P/E ratio for Adherium Ltd. (ADR:ASX) is .
The current share price of Adherium Ltd. (ADR:ASX) is AU$0.0045.
The 52-week high share price for Adherium Ltd. (ADR:ASX) is AU$0.01.
The 52-week low share price for Adherium Ltd. (ADR:ASX)? is AU$0.00.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) does not pay a dividend.
Adherium Ltd. (ADR:ASX) has a franking level of 0.0%.
Adherium Ltd. (ADR:ASX) is classified in the Healthcare.
The current P/E ratio for Adherium Ltd. (ADR:ASX) is .